Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| London School of Hygiene and Tropical Medicine | OTHER |
| Nutriset | INDUSTRY |
| United Nations World Food Programme (WFP) | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Since 2001, Ready to Use Therapeutic Foods (RUTF) are widely used to treat severe malnutrition. Their efficacy and effectiveness were proven in community therapeutic care programs. Recently, the question rose if RUTF would be more effective than enriched flours to treat moderate malnutrition.
The purpose of this study is to compare the effectiveness of Ready to Use Food Supplementary-plumpy® and Premix Corn Soy Blend with oil in term of cure rate, weight gain, duration of treatment, morbidity and mortality in the treatment of moderate acute malnutrition.
Compare the longer term effect on nutritional status and morbidity (relapse?).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Ready to Use Supplementary Food | Active Comparator | Ready to Use Supplementary Food treatment |
|
| Premix | Active Comparator | Premix Corn Soy Blend-oil treatment |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Ready to Use Supplementary Food | Dietary Supplement | Children received two Supplementary-plumpy® packages per day (184g) providing 1000 Kcal, 26g (10.4%) protein, 68g (61.2%) fat, and 100% of micronutrient requirements based on the Daily Recommended Nutrient Intake. |
| Measure | Description | Time Frame |
|---|---|---|
| Recovery | proportion of children who recovered, defined as WHM> 85% for two consecutive weeks | 112 days |
| Measure | Description | Time Frame |
|---|---|---|
| average weight gain | in g per kg of weight per day | 112 days |
| Duration of treatment | average length of stay in days. | 112 days |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pascale Delchevalerie, Msc | Medecins Sans Frontieres, Netherlands | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Health Centers run by MSF and MOH | Bo | Bo | Sierra Leone |
Not provided
| ID | Term |
|---|---|
| D008224 | Lymphoma, Follicular |
| D002100 | Cachexia |
| D044342 | Malnutrition |
| ID | Term |
|---|---|
| D008228 | Lymphoma, Non-Hodgkin |
| D008223 | Lymphoma |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Premix CSB-oil treatment | Dietary Supplement | Children received 2 kg of premix per week (226g CSB, 37g oil, and 23g sugar / day) providing 1277 Kcal, 40.7g protein (12.7%), 50.6g (35.7%) fat, and 100% of micronutrient according to the DRNI guidelines |
|
|
| Morbidity | number of morbidity episodes during the treatment and six months thereafter | 11 months |
| D008232 |
| Lymphoproliferative Disorders |
| D008206 | Lymphatic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D007160 | Immunoproliferative Disorders |
| D007154 | Immune System Diseases |
| D015431 | Weight Loss |
| D001836 | Body Weight Changes |
| D001835 | Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D013851 | Thinness |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |